Rural Health
Resources by Topic: Behavioral health
Roadmap for Resilience: The California Surgeon General's Report on Adverse Childhood Experiences, Toxic Stress, and Health
Reports on Adverse Childhood Experiences (ACEs) and toxic stress in California, addressing the health impacts of ACEs and stress, economic costs, and public health implications of the issue. Discusses initiatives that increase access to screening and treatment for ACEs in urban, rural, and tribal communities. Explores prevention strategies among public health, social service, early childhood, education, and justice agencies.
Author(s): Devika Bhushan, Krista Kotz, Julianne McCall, et al.
Date: 12/2020
Sponsoring organization: California Office of the Surgeon General
view details
Reports on Adverse Childhood Experiences (ACEs) and toxic stress in California, addressing the health impacts of ACEs and stress, economic costs, and public health implications of the issue. Discusses initiatives that increase access to screening and treatment for ACEs in urban, rural, and tribal communities. Explores prevention strategies among public health, social service, early childhood, education, and justice agencies.
Author(s): Devika Bhushan, Krista Kotz, Julianne McCall, et al.
Date: 12/2020
Sponsoring organization: California Office of the Surgeon General
view details
Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine
Highlights a study on the geographic distribution of Medicaid-claimant obstetrician-gynecologists trained to prescribe buprenorphine for opioid use disorder. Compares provider prevalence in rural versus urban counties.
Author(s): Max Jordan Nguemeni Tiako, Jennifer Culhane, Eugenia South, et al.
Citation: JAMA Network Open, 3(12), e2029043
Date: 12/2020
view details
Highlights a study on the geographic distribution of Medicaid-claimant obstetrician-gynecologists trained to prescribe buprenorphine for opioid use disorder. Compares provider prevalence in rural versus urban counties.
Author(s): Max Jordan Nguemeni Tiako, Jennifer Culhane, Eugenia South, et al.
Citation: JAMA Network Open, 3(12), e2029043
Date: 12/2020
view details
Impacts of COVID-19 on Rural Mental Health
Presentation slides from an American Farm Bureau Federation poll of 2,000 rural adults in December 2020, comparing results to a similar April 2019 poll. Addresses perceived importance of mental health, issues of stigma, impacts of the COVID-19 pandemic on mental health, barriers to care, and other mental health topics. Tracks response trends between 2019 and 2020, highlighting consistent aspects of the survey and changes in impressions and experiences.
Date: 12/2020
Sponsoring organization: American Farm Bureau Federation
view details
Presentation slides from an American Farm Bureau Federation poll of 2,000 rural adults in December 2020, comparing results to a similar April 2019 poll. Addresses perceived importance of mental health, issues of stigma, impacts of the COVID-19 pandemic on mental health, barriers to care, and other mental health topics. Tracks response trends between 2019 and 2020, highlighting consistent aspects of the survey and changes in impressions and experiences.
Date: 12/2020
Sponsoring organization: American Farm Bureau Federation
view details
How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing?
Explores if regulatory changes to increase the patient capacity among buprenorphine waivered providers effects buprenorphine and opioids prescription rates at the county-level. Compares prescription rates by metropolitan and non-metropolitan counties.
Author(s): Robin Ghertner, Mir M. Ali
Date: 12/2020
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Explores if regulatory changes to increase the patient capacity among buprenorphine waivered providers effects buprenorphine and opioids prescription rates at the county-level. Compares prescription rates by metropolitan and non-metropolitan counties.
Author(s): Robin Ghertner, Mir M. Ali
Date: 12/2020
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Cost-Effectiveness of Scaling Up HCV Prevention and Treatment in the United States for People Who Inject Drugs
Highlights the cost-effectiveness of combining medication-assisted treatment (MAT) and syringe-service programs (SSP) with hepatitis C (HCV) treatment for people who inject drugs. Compares services for patients in rural Perry County, KY; and urban San Francisco, CA.
Author(s): Carolina Barbosa, Hannah Fraser, Thomas J. Hoerger, et al.
Citation: Addiction, 114(12), 2267-2278
Date: 12/2020
view details
Highlights the cost-effectiveness of combining medication-assisted treatment (MAT) and syringe-service programs (SSP) with hepatitis C (HCV) treatment for people who inject drugs. Compares services for patients in rural Perry County, KY; and urban San Francisco, CA.
Author(s): Carolina Barbosa, Hannah Fraser, Thomas J. Hoerger, et al.
Citation: Addiction, 114(12), 2267-2278
Date: 12/2020
view details
Substance Use Disorder Treatment Penetration among Child Welfare-Involved Caregivers
Highlights rates of substance use disorder (SUD) and SUD treatment among child welfare-involved caregivers in Washington. Breaks down data by county and by caregivers with SUD and those receiving treatment for SUD.
Additional links: Supplemental Maps
Author(s): Deleena Patton, Qinghua Liu, Ellen Kersten, et al.
Date: 12/2020
Sponsoring organization: Washington State Department of Social and Health Services
view details
Highlights rates of substance use disorder (SUD) and SUD treatment among child welfare-involved caregivers in Washington. Breaks down data by county and by caregivers with SUD and those receiving treatment for SUD.
Additional links: Supplemental Maps
Author(s): Deleena Patton, Qinghua Liu, Ellen Kersten, et al.
Date: 12/2020
Sponsoring organization: Washington State Department of Social and Health Services
view details
Medicare Fee-For-Service Beneficiaries with Opioid Use Disorder in 2018: Disparities in Prevalence by Beneficiary Characteristics
Examines the sociodemographic, Medicare eligibility, clinical, and geographic characteristics of Medicare beneficiaries with opioid use disorder (OUD). Identifies disparities in OUD prevalence among Medicare beneficiaries. Discusses opportunities to tailor policies and interventions to beneficiary groups with high OUD prevalence to ensure access to treatment.
Date: 12/2020
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Examines the sociodemographic, Medicare eligibility, clinical, and geographic characteristics of Medicare beneficiaries with opioid use disorder (OUD). Identifies disparities in OUD prevalence among Medicare beneficiaries. Discusses opportunities to tailor policies and interventions to beneficiary groups with high OUD prevalence to ensure access to treatment.
Date: 12/2020
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
Montana Chronic Disease Prevention & Health Promotion Bureau: June 2018-July 2020 Progress Report
Report highlights the public health efforts in the areas of tobacco cessation, diabetes and cancer reduction, and promoting physical activity, among other issues in Montana. Compares rates over a two year span and details the programs designed to address them.
Date: 12/2020
Sponsoring organization: Montana Department of Public Health and Human Services
view details
Report highlights the public health efforts in the areas of tobacco cessation, diabetes and cancer reduction, and promoting physical activity, among other issues in Montana. Compares rates over a two year span and details the programs designed to address them.
Date: 12/2020
Sponsoring organization: Montana Department of Public Health and Human Services
view details
Opioids in Medicaid: Concerns About Opioid Use Among Beneficiaries in Six Appalachian States in 2018
Examines the rates of opioid use of Medicaid beneficiaries in 6 Appalachian states in 2018. Discusses the amount of the prescriptions issued, the amounts of opioids received, and the amount of providers with questionable prescribing practices, among other opioid-related measures.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Examines the rates of opioid use of Medicaid beneficiaries in 6 Appalachian states in 2018. Discusses the amount of the prescriptions issued, the amounts of opioids received, and the amount of providers with questionable prescribing practices, among other opioid-related measures.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Few Patients Received High Amounts of Opioids from IHS-Run Pharmacies
Presents an evaluation of the opioid prescribing practices of the Indian Health Service (IHS). Bases analysis on IHS opioid prescribing data, discusses the role of electronic health records (EHRs) in monitoring opioid prescriptions, and makes recommendations to improve monitoring.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Presents an evaluation of the opioid prescribing practices of the Indian Health Service (IHS). Bases analysis on IHS opioid prescribing data, discusses the role of electronic health records (EHRs) in monitoring opioid prescriptions, and makes recommendations to improve monitoring.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details